Kiniksa Pharmaceuticals, Ltd. - stock earnings
KNSA Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| June 5, 2024 BeforeMarket | - / - | 75.0 million | - / 78.5 million | 83.0 million |
| July 23, 2024 BeforeMarket | - / - | 86.0 million | - / 89.3 million | 92.0 million |
KNSA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | -17.7 million USD | 79.9 million USD |
| 2023Q4 | 25.2 million USD | 83.4 million USD |
| 2023Q3 | -13.9 million USD | 67.0 million USD |
| 2023Q2 | 15.0 million USD | 71.5 million USD |
| 2023Q1 | -12.3 million USD | 48.3 million USD |
| 2022Q4 | 4.5 million USD | 61.9 million USD |
| 2022Q3 | 224.1 million USD | 99.1 million USD |
| 2022Q2 | -20.0 million USD | 27.0 million USD |
| 2022Q1 | -25.2 million USD | 32.2 million USD |
| 2021Q4 | -36.3 million USD | 18.7 million USD |
| 2021Q3 | -30.5 million USD | 12.1 million USD |
| 2021Q2 | -41.6 million USD | 7.7 million USD |
| 2021Q1 | -49.5 million USD | ? USD |
| 2020Q4 | -53.7 million USD | ? USD |
| 2020Q3 | -43.8 million USD | ? USD |
| 2020Q2 | -37.5 million USD | ? USD |
| 2020Q1 | -26.4 million USD | ? USD |
| 2019Q4 | -31.8 million USD | ? USD |
| 2019Q3 | -27.1 million USD | ? USD |
| 2019Q2 | -37.2 million USD | ? USD |
| 2019Q1 | -65.8 million USD | ? USD |
| 2018Q4 | -42.6 million USD | ? USD |
| 2018Q3 | -24.4 million USD | ? USD |
| 2018Q2 | -20.3 million USD | ? USD |
| 2018Q1 | -16.0 million USD | ? USD |
| 2017Q4 | -32.7 million USD | ? USD |
| 2017Q3 | -16.0 million USD | ? USD |
| 2017Q2 | -11.2 million USD | ? USD |
| 2017Q1 | -4.9 million USD | ? USD |
| 2016Q4 | -24.0 million USD | ? USD |
KNSA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 14.1 million USD | 270.3 million USD |
| 2022 | 183.4 million USD | 220.2 million USD |
| 2021 | -157.9 million USD | 38.5 million USD |
| 2020 | -161.4 million USD | 7.7 million USD |
| 2019 | -161.9 million USD | ? USD |
| 2018 | -103.2 million USD | ? USD |
| 2017 | -64.9 million USD | ? USD |
| 2016 | -24.0 million USD | ? USD |
KNSA
Price: $17.88
52 week price:
Earnings Per Share: 0.20 USD
P/E Ratio: -183.36
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 221500
Market Capitalization: 1.2 billion